A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the Treatment of Non-Small Cell Lung Cancer With Multiple Metastases

Inclusion Criteria

• •1. Non-small cell lung cancer diagnosed initially through pathological histology.
• •2. There are 3-6 metastatic lesions.
• •3. No brain metastasis or the lesions are stable.
• •4. Negative for driver genes (including EGFR, ALK, ROS, BRAF, MET, RET genes. Note: The above English terms are all gene names).
• •5. ECOG (Eastern Cooperative Oncology Group) score: 0-1 point, with an expected, survival period of more than 3 months.
• •6. Aged between 18 and 75 years old.
• •7. Evaluated by PET-CT (including FDG and FMISO, not mandatory).
• •8. No contraindications for immunotherapy and radiotherapy.
• •9. The informed consent form has been signed.